Article

Parry becomes new AMDAI chairman

Hugh R. Parry has been named chairman of the board of AMD Alliance International (AMDAI), an international organization dedicated exclusively to macular disease.Parry, president and CEO of Prevent Blindness America, was appointed during the annual board meeting of AMDAI in New York on April 16, 2010.

Chicago-Hugh R. Parry has been named chairman of the board of AMD Alliance International (AMDAI), an international organization dedicated exclusively to macular disease.

Parry, president and CEO of Prevent Blindness America, was appointed during the annual board meeting of AMDAI in New York on April 16, 2010.

AMDAI is a consortium of 70 of the world's leading vision, seniors, and research organizations in 25 countries. Its goal is to bring knowledge, hope, and help to individuals and families around the globe affected by age-related macular degeneration (AMD). There are 30 million people affected by AMD worldwide and that number is predicted to triple over the next 10 years given the aging population.

“Eye diseases, such as macular degeneration, cross all borders,” said Parry. “I am honored to be chosen to chair this organization of dedicated individuals from around the world so that we may put forth a collaborative effort to help put an end to unnecessary vision loss.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.